These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21552898)

  • 1. New antagonists of bombesin gastrin-releasing Peptide with C-terminal leu-psi-(ch2n)tac-nh2.
    Reile H; Cai R; Armatis P; Schally A
    Int J Oncol; 1995 Oct; 7(4):749-54. PubMed ID: 21552898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pseudononapeptide bombesin antagonists with C-terminal leu-psi(ch2n)tac-nh2 show high binding-affinity to bombesin/grp receptors on cfpac-1 human pancreatic-cancer cells.
    Cai R; Qin Y; Ertl T; Schally A
    Int J Oncol; 1995 Jun; 6(6):1165-72. PubMed ID: 21556653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
    Cai RZ; Reile H; Armatis P; Schally AV
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
    Cai RZ; Radulovic S; Pinski J; Nagy A; Redding TW; Olsen DB; Schally AV
    Peptides; 1992; 13(2):267-71. PubMed ID: 1409006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of new bombesin antagonists given singly or in combination with a somatostatin analog on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally A; Cai R; Halmos G; Groot K
    Int J Oncol; 1996 Sep; 9(3):397-403. PubMed ID: 21541526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi.
    Radulovic S; Cai RZ; Serfozo P; Groot K; Redding TW; Pinski J; Schally AV
    Int J Pept Protein Res; 1991 Dec; 38(6):593-600. PubMed ID: 1726427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
    Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC; Leban JJ; Landavazo A; Stewart KD; Stockstill B; McDermed JD
    J Biol Chem; 1992 Oct; 267(29):21132-8. PubMed ID: 1400423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.
    Nagy A; Armatis P; Cai RZ; Szepeshazi K; Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):652-6. PubMed ID: 9012839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
    Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
    Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
    Nyéki O; Rill A; Schon I; Orosz A; Schrett J; Bartha L; Nagy J
    J Pept Sci; 1998 Dec; 4(8):486-95. PubMed ID: 9927255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats.
    Pinski J; Yano T; Groot K; Cai RZ; Radulovic S; Schally AV
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E712-7. PubMed ID: 1415689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
    González N; Mantey SA; Pradhan TK; Sancho V; Moody TW; Coy DH; Jensen RT
    Peptides; 2009 Aug; 30(8):1473-86. PubMed ID: 19463875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic development of bombesin/gastrin-releasing peptide antagonists.
    Coy DH; Jensen RT; Jiang NY; Lin JT; Bogden AE; Moreau JP
    J Natl Cancer Inst Monogr; 1992; (13):133-9. PubMed ID: 1389686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells.
    Wang LH; Coy DH; Taylor JE; Jiang NY; Kim SH; Moreau JP; Huang SC; Mantey SA; Frucht H; Jensen RT
    Biochemistry; 1990 Jan; 29(3):616-22. PubMed ID: 1692477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.